Organovo Holdings, Inc. (ONVO)

[rookiecrd1]

Regenerative medicine to exceed $500 billion in the next 20 years.

According to the United States Department of Health

Regenerative medicine will dramatically alter the U.S. healthcare industry
The potential benefits of regenerative medicine - in improved health care and economic savings - are enormous. Already, the direct healthcare costs of organ replacement are about $350 billion globally (about 8 percent of global healthcare spending). These costs arise from therapies that keep people alive (such as kidney dialysis), implanted replacement devices, and very few (due to lack of donors) organ transplants.(7) With a $350 billion global industry already built on first generation tissue and organ therapy products and substitutes, regenerative medicine has potential to exceed $500 billion in the next 20 years.

Full report here:

http://pastehtml.com/view/c3twpz4ca.html